Search results
This BriaCell Therapeutics Insider Increased Their Holding By 55% Last Year
Simply Wall St. via Yahoo Finance· 3 days agoLooking at BriaCell Therapeutics Corp.'s (TSE:BCT ) insider transactions over the last year, we can...
Investors Purchase High Volume of Sarepta Therapeutics Call Options (NASDAQ:SRPT)
ETF DAILY NEWS· 4 days agoSarepta Therapeutics, Inc. (NASDAQ:SRPT – Get Free Report) was the recipient of some unusual options trading on Tuesday. Traders bought 3,559 call options on the stock. This ...
Arcturus Therapeutics (NASDAQ:ARCT) Stock Price Up 5.8%
ETF DAILY NEWS· 3 days agoArcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Get Free Report) shares were up 5.8% during trading on Wednesday . The company traded as high as $31.59 and last traded ...
Neumora Therapeutics, Inc. (NASDAQ:NMRA) Receives Consensus Recommendation of “Moderate Buy” from...
ETF DAILY NEWS· 5 days agoNeumora Therapeutics, Inc. (NASDAQ:NMRA – Get Free Report) has received an average rating of “Moderate Buy” from the seven analysts that are currently covering the company ...
Dyne Therapeutics (NASDAQ:DYN) Price Target Increased to $48.00 by Analysts at HC Wainwright
ETF DAILY NEWS· 6 days agoDyne Therapeutics (NASDAQ:DYN – Free Report) had its target price lifted by HC Wainwright from $36.00 to $48.00 in a research note released on Monday, Benzinga reports. Chardan ...
PTC Therapeutics (PTCT) Up as EC Returns CHMP Opinion on DMD Drug
Zacks via Yahoo Finance· 6 days agoPTC Therapeutics (PTCT) gains 21% on May 20 after the EC decided against adopting the negative CHMP...
News Flash: Analysts Just Made A Notable Upgrade To Their PTC Therapeutics, Inc. (NASDAQ:PTCT)...
Simply Wall St. via Yahoo Finance· 5 days agoPTC Therapeutics, Inc. (NASDAQ:PTCT) shareholders will have a reason to smile today, with the...
Is CRISPR Therapeutics a Millionaire Maker?
Motley Fool via Yahoo Finance· 5 days agoWith a gene therapy for two illnesses out the door, and with sales slated to take off over the next few quarters, CRISPR Therapeutics (NASDAQ: CRSP) is...
Allogene Therapeutics, Inc. (NASDAQ:ALLO) to Post Q2 2024 Earnings of ($0.35) Per Share, HC...
ETF DAILY NEWS· 6 days agoAllogene Therapeutics, Inc. (NASDAQ:ALLO – Free Report) – HC Wainwright raised their Q2 2024 earnings estimates for shares of Allogene Therapeutics in a ...
We're Keeping An Eye On Tenaya Therapeutics' (NASDAQ:TNYA) Cash Burn Rate
Simply Wall St. via Yahoo Finance· 2 days agoBut while history lauds those rare successes, those that fail are often forgotten; who remembers...